Evidence map›Paper›PMID 40722674›Full record

ReviewBiomedicines2025

Therapeutic Potential of Rho Kinase Inhibitors in Corneal Disease: A Systematic Review of Preclinical and Clinical Studies.

Laura Andreea Ghenciu, Diana Andrei, Claudia Borza, Roxana Iacob, Emil Robert Stoicescu, Sorin Lucian Bolintineanu, Daniela Iacob, Ovidiu Alin Haţegan

Abstract readReview
In one paragraph

Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura Andreea GhenciuDiscipline of Pathophysiology, Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy Timisoara, Square Eftimie Murgu 2, 300041 Timisoara, Romania.ORCID 0000-0002-5326-5438
Diana AndreiDepartment of Balneology, Medical Rehabilitation and Rheumatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Square Eftimie Murgu 2, 300041 Timisoara, Romania.ORCID 0000-0001-6019-9734
Claudia BorzaDiscipline of Pathophysiology, Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy Timisoara, Square Eftimie Murgu 2, 300041 Timisoara, Romania.
Roxana IacobDepartment of Anatomy and Embriology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Square Eftimie Murgu 2, 300041 Timisoara, Romania.ORCID 0000-0002-2894-712X
Emil Robert StoicescuField of Applied Engineering Sciences, Specialization Statistical Methods and Techniques in Health and Clinical Research, Faculty of Mechanics, "Politehnica" University Timisoara, Mihai Viteazul Boulevard No. 1, 300222 Timisoara, Romania.ORCID 0000-0003-4620-3340
Sorin Lucian BolintineanuDepartment of Anatomy and Embriology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Square Eftimie Murgu 2, 300041 Timisoara, Romania.
Daniela IacobDepartment of Neonatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Square Eftimie Murgu 2, 300041 Timisoara, Romania.ORCID 0000-0003-2468-6003
Ovidiu Alin HaţeganDiscipline of Anatomy and Embriology, Medicine Faculty, "Vasile Goldis" Western University of Arad, Revolution Boulevard 94, 310025 Arad, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bullous keratopathyFuchs dystrophylimbal stem cells deficiencynetarsudilRho kinase inhibitorsripasudilROCK inhibitors

Identifiers

PMID40722674
PMCPMC12292609

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.